Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Judy, Wen"'
Autor:
Sarah Katharina Fehling, Louis Fries, Jay W. Hooper, Stephan Becker, Judy Wen, Verena Krähling, Gale Smith, Gregory M. Glenn, David Flyer, Thomas Strecker, Sapeckshita Agrawal, Amy Fix, Steven A. Kwilas, Nigel Thomas, Maggie Lewis, Iksung Cho
Publikováno v:
The Journal of Infectious Diseases. 222:572-582
Background Ebola virus (EBOV) epidemics pose a major public health risk. There currently is no licensed human vaccine against EBOV. The safety and immunogenicity of a recombinant EBOV glycoprotein (GP) nanoparticle vaccine formulated with or without
Autor:
Shabir A, Madhi, Fernando P, Polack, Pedro A, Piedra, Flor M, Munoz, Adrian A, Trenholme, Eric A F, Simões, Geeta K, Swamy, Sapeckshita, Agrawal, Khatija, Ahmed, Allison, August, Abdullah H, Baqui, Anna, Calvert, Janice, Chen, Iksung, Cho, Mark F, Cotton, Clare L, Cutland, Janet A, Englund, Amy, Fix, Bernard, Gonik, Laura, Hammitt, Paul T, Heath, Joanne N, de Jesus, Christine E, Jones, Asma, Khalil, David W, Kimberlin, Romina, Libster, Conrado J, Llapur, Marilla, Lucero, Gonzalo, Pérez Marc, Helen S, Marshall, Masebole S, Masenya, Federico, Martinón-Torres, Jennifer K, Meece, Terry M, Nolan, Ayman, Osman, Kirsten P, Perrett, Joyce S, Plested, Peter C, Richmond, Matthew D, Snape, Julie H, Shakib, Vivek, Shinde, Tanya, Stoney, D Nigel, Thomas, Alan T, Tita, Michael W, Varner, Manu, Vatish, Keith, Vrbicky, Judy, Wen, Khalequ, Zaman, Heather J, Zar, Gregory M, Glenn, Louis F, Fries, Shirley, Wong
Publikováno v:
The New England Journal of Medicine
Summary of study A multi-country randomized, placebo-controlled trial of the safety, immunogenicity and efficacy of respiratory syncytial virus (RSV) F-protein nanoparticle vaccine was undertaken in 4,636 pregnant women and their infants. RSV F-prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044f72715b6fa6e69a67d216cd8eb81e
https://openaccess.sgul.ac.uk/id/eprint/112223/1/nejmoa1908380.pdf
https://openaccess.sgul.ac.uk/id/eprint/112223/1/nejmoa1908380.pdf
Autor:
Amy Fix, D. Nigel Thomas, Joyce S. Plested, Chang-Min Chen, Louis Fries, Gregory M. Glenn, Michelle Spindler, Judy Wen, Iksung Cho
Publikováno v:
Open Forum Infectious Diseases
Background Respiratory syncytial virus (RSV) is the leading viral cause of severe lower respiratory tract infection (LRTI) in infants worldwide, with severe disease occurring in the first months of life. We assessed the efficacy of maternal immunizat
Autor:
Pedro A. Piedra, Eloi Kpamegan, D. Nigel Thomas, Allison August, Judy Wen, Gregory M. Glenn, Dewal Jani, Hanxin Lu, Louis Fries, Somia P. Hickman
Publikováno v:
Vaccine. 35(30)
Objective Respiratory syncytial virus (RSV) causes significant morbidity and mortality in infants. We are developing an RSV fusion (F) protein nanoparticle vaccine for immunization of third trimester pregnant women to passively protect infants throug
Publikováno v:
Cancer Immunology, Immunotherapy. 53:33-40
We previously characterized the expression of CD80 in different murine head and neck squamous cell carcinoma (HNSCC) clones derived following tumor progression in the absence of T cell-mediated immunity in severe combined immunodeficient (SCID) mice.
Autor:
Andrew Davidoff, Shigeru Takamizawa, Anthony D. Sandler, David Scott, Judy Wen, Takeo Azuhata, Masahiro Fukuzawa
Publikováno v:
Journal of Pediatric Surgery. 36:1785-1791
Background/Purpose: Apoptotic factors inducing or preventing cell death may intrinsically govern the behavior of some tumors. Survivin is a recently described member of the inhibitor of apoptosis protein (IAP) family, that is expressed in a cell cycl
Autor:
Shigeru Takamizawa, Anthony D. Sandler, Shinya Okamoto, Ken Kimura, Judy Wen, Warren P. Bishop
Publikováno v:
Journal of Pediatric Surgery. 35:390-395
Apoptosis, or programmed cell death, is essential in maintaining normal homeostasis of tissues. The process of apoptosis is controlled by numerous pro- and antiapoptotic factors. Variations in expression of such factors may account for some variation
Autor:
Anthony D. Sandler, Warren P. Bishop, Judy Wen, Ken Kimura, Shigeru Takamizawa, Shinya Okamoto
Publikováno v:
Journal of Surgical Research. 84:77-81
Background, Fas ligand (Fas-L) is thought to provide immune privilege to specific tissues and tumors by inducing an apoptotic signal of cytotoxic T cells expressing its Fas receptor. Purpose. The purpose of this work was to evaluate whether an immort
Autor:
Judy Wen, Lutecia Pereira, Kermit L. Carraway, Elizabeth J. Franzmann, David M. Neskey, W. Jarrard Goodwin, Aymee Perez, Erika P. Reategui
Publikováno v:
Oral oncology. 49(4)
summary Objectives: CD44 is a promising target for therapy in head and neck squamous cell carcinoma (HNSCC) and has two defined roles in tumorigenesis: it is a cancer stem cell (CSC) marker and it promotes migration and proliferation through interact
Autor:
Giovana R, Thomas, Judy, Wen
Publikováno v:
Anticancer research. 26(6B)
Most tumor tissues, especially those of non-hematopoietic origin, do not express CD80 co-stimulatory molecules, possibly as a mechanism to evade immune surveillance. The objective of this study was to determine whether abundant endogenous CD80 expres